Who is sponsoring NCT03224312?

NCT03224312 is sponsored by Chongqing Medical University.

What condition does NCT03224312 study?

NCT03224312 studies Primary Aldosteronism.

What drugs are being tested in NCT03224312?

Interventions: no intervention.

What is the status of NCT03224312?

NCT03224312 is currently RECRUITING.

Last reviewed 2023-09-06 · How we verify

Chongqing Primary Aldosteronism Study

NCT03224312 RECRUITING

We intends to conduct a series of original clinical research about PA, and establish a large cohort of PA and essential hypertension patients with long-term follow-up of cardiovascular events, renal end points etc. We will establish a large sample of blood, urine, adrenal tissue of the subjects, and the genomics,metabonomics, proteomics database, to explore the mechanism of the PA and target organ damage, risk factors, diagnostic methods and biomarkers.

Details

Lead sponsor	Chongqing Medical University
Status	RECRUITING
Enrolment	1500
Start date	Sat Oct 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Sun Dec 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Primary Aldosteronism

Interventions

no intervention

Countries

China